Mesh.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Catechol O-Methyltransferase Inhibitors »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Catechol O-Methyltransferase < Catechol O-Methyltransferase Inhibitors < Catecholamines  Facettes :

List of bibliographic references indexed by Catechol O-Methyltransferase Inhibitors

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000483 (2015) James A. G. Crispo [États-Unis] ; Yannick Fortin ; Dylan P. Thibault [États-Unis] ; Matthew Emons [États-Unis] ; Lise M. Bjerre ; Dafna E. Kohen ; Santiago Perez-Lloret [Argentine] ; Donald Mattison ; Allison W. Willis [États-Unis] ; Daniel KrewskiTrends in inpatient antiparkinson drug use in the USA, 2001–2012
001C52 (2010) A. Jon Stoessl [Canada]Continuous dopaminergic therapy in Parkinson disease: Time to stride back?
002724 (2006) Alex Rajput [Canada] ; Ali H. RajputParkinson's disease management strategies.
002A01 (2005) Tom H. Johnston [Canada] ; Susan H. Fox ; Jonathan M. BrotchieAdvances in the delivery of treatments for Parkinson's disease.
002F65 (2002) Oksana Suchowersky [Canada]Parkinson's disease: medical treatment of moderate to advanced disease.
003378 (2000) P. Watkins [États-Unis]COMT inhibitors and liver toxicity.
003808 (1999) M. Guttman [Canada] ; O. Suchowersky [Canada]Parkinson's disease management : Towards a new paradigm
003836 (1999) J. Rivest [Canada] ; C. L. Barclay [Canada] ; O. Suchowersky [Canada]COMT inhibitors in Parkinson's disease
003A14 (1998) A. H. Rajput [Canada] ; W. Martin [Canada] ; M.-H. Saint-Hilaire [États-Unis] ; E. Dorflinger [États-Unis] ; S. Pedder [États-Unis]Tolcapone improves motor function in parkinsonian patients with the "wearing-off" phenomenon : A double-blind, placebo-controlled, multicenter trial
005588 (????) D J Chong [Canada] ; O. Suchowersky ; C. Szumlanski ; R M Weinshilboum ; R. Brant ; N R CampbellThe relationship between COMT genotype and the clinical effectiveness of tolcapone, a COMT inhibitor, in patients with Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Catechol O-Methyltransferase Inhibitors" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Catechol O-Methyltransferase Inhibitors" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Catechol O-Methyltransferase Inhibitors
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022